Pulse Biosciences (PLSE) Shares Outstanding (2015 - 2026)

Pulse Biosciences has reported Shares Outstanding (Entity) for 12 years, with the latest figure at $70.8 million in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 5.23% year-over-year to $70.8 million in Q2 2026; TTM through Jun 2026 was $70.8 million, a 5.23% increase from a year earlier, with the FY2025 full-year figure at $67.8 million, up 2.9% from the prior year.
• Shares Outstanding (Entity) was $70.8 million for Q2 2026 at Pulse Biosciences, up from $67.8 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $70.8 million in Q2 2026, with the low at $29.8 million in Q1 2022.
• Average Shares Outstanding (Entity) over 5 years is $53.7 million, with a median of $55.2 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Entity) soared 48.1% in 2023, then rose 2.9% in 2025.
• Over 5 years, Shares Outstanding (Entity) stood at $37.2 million in 2022, then jumped by 48.1% to $55.1 million in 2023, then increased by 19.55% to $65.9 million in 2024, then advanced by 2.9% to $67.8 million in 2025, then climbed by 4.36% to $70.8 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $70.8 million (Q2 2026), $67.8 million (Q4 2025), and $67.7 million (Q3 2025), per Business Quant data.